Statin-induced apoptosis and skeletal myopathy

American Journal of Physiology - Cell Physiology

Volumn 291, Issue 6, 2006, Pages

  Dirks, Amie J ^a   Jones, Kimberly M ^a  

^a WINGATE UNIVERSITY   (United States)

Author keywords

3 hydroxy 3 methylglutaryl coenzyme A; Cell death; Reductase inhibitors; Skeletal muscle

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVALONIC ACID;

APOPTOSIS; ARTICLE; CANCER; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; DIABETES MELLITUS; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG INHIBITION; DRUG USE; EXERCISE; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERCHOLESTEROLEMIA; MUSCLE CRAMP; MUSCLE FATIGUE; MYOPATHY; OSTEOPOROSIS; PAIN; PHYSICIAN; PLEIOTROPY; PRESCRIPTION; PRIORITY JOURNAL; RARE DISEASE; RHABDOMYOLYSIS; SKELETAL MUSCLE; WEAKNESS;

ANTICHOLESTEREMIC AGENTS; APOPTOSIS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MITOCHONDRIA; MUSCLE, SKELETAL; MUSCULAR DISEASES;

EID: 33845306820     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00226.2006     Document Type: Article

References (50)

1. Adams JM and Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326, 1998.
2. Antonsson B, Conti F, Ciavatta A, Montessuit S, Lewis S, Martinou I, Bernasconi L, Bernard A, Mermod JJ, Mazzei G, Maundrell K, Gambale F, Sadoul R, and Martinou JC. Inhibition of Bax channel-forming activity by Bcl-2. Science 277: 370-372, 1997.
3. Blanco-Colio LM, Villa A, Ortego M, Hernandez-Presa MA, Pascual A, Plaza JJ, and Egido J. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation. Atherosclerosis 161: 17-26, 2002.
4. Boucher K, Siegel CS, Sharma P, Hauschka PV, and Solomon KR. HMG-CoA reductase inhibitors induce apoptosis in pericytes. Microvasc Res 71: 91-102, 2006.
5. Cafforio P, Dammacco F, Gernone A, and Silvestris F. Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells. Carcinogenesis 26: 883-891, 2005.
6. Daugas E, Nochy D, Ravagnan L, Loeffler M, Susin SA, Zamzami N, and Kroemer G. Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis. FEBS Lett 476: 118-123, 2000.
7. Daugas E, Susin SA, Zamzami N, Ferri KF, Irinopoulou T, Larochette N, Prevost MC, Leber B, Andrews D, Penninger J, and Kroemer G. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J 14: 729-739, 2000.
8. Demyanets S, Kaun C, Pfaffenberger S, Hohensinner PJ, Rega G, Pammer J, Maurer G, Huber K, and Wojta J. Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro. Biochem Pharmacol 71: 1324-1330, 2006.
9. Dirks A and Leeuwenburgh C. Apoptosis in skeletal muscle with aging. Am J Physiol Regul Integr Comp Physiol 282: R519-R527, 2002.
10. Dirks AJ and Leeuwenburgh C. Aging and lifelong calorie restriction result in adaptations of skeletal muscle apoptosis repressor, apoptosis-inducing factor, X-linked inhibitor of apoptosis, caspase-3, and caspase-12. Free Radic Biol Med 36: 27-39, 2004.
11. Ekhterae D, Lin Z, Lundberg MS, Crow MT, Brosius FC III, and Nunez G. ARC inhibits cytochrome c release from mitochondria and protects against hypoxia-induced apoptosis in heart-derived H9c2 cells. Circ Res 85: e70-e77, 1999.
12. Erl W. Statin-induced vascular smooth muscle cell apoptosis: a possible role in the prevention of restenosis? Current Drug Targets Cardiovasc Haematol Disord 5: 135-144, 2005.
13. Fromigue O, Hay E, Modrowski D, Bouvet S, Jacquel A, Auberger P, and Marie PJ. RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation. Cell Death Differ. In Press.
14. Graaf MR, Richel DJ, van Noorden CJ, and Guchelaar HJ. Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer. Cancer Treat Rev 30: 609-641, 2004.
15. Green DR. Apoptotic pathways: paper wraps stone blunts scissors. Cell 102: 1-4, 2000.
16. Gross A, McDonnell JM, and Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13: 1899-1911, 1999.
17. Guijarro C, Blanco-Colio LM, Ortego M, Alonso C, Ortiz A, Plaza JJ, Diaz C, Hernandez G, and Egido J. 3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture. Circ Res 83: 490-500, 1998.
18. Gustafsson AB, Tsai JG, Logue SE, Crow MT, and Gottlieb RA. Apoptosis repressor with caspase recruitment domain protects against cell death by interfering with Bax activation. J Biol Chem 279: 21233-21238, 2004.
19. Johnson TE, Zhang X, Bleicher KB, Dysart G, Loughlin AF, Schaefer WH, and Umbenhauer DR. Statins induce apoptosis in rat and human myotube cultures by inhibiting protein geranylgeranylation but not ubiquinone. Toxicol Appl Pharmacol 200: 237-250, 2004.
20. Kerr JF, Wyllie AH, and Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257, 1972.
21. Kluck RM, Bossy-Wetzel E, Green DR, and Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136, 1997.
22. Koumis T, Nathan JP, Rosenberg JM, and Cicero LA. Strategies for the prevention and treatment of statin-induced myopathy: is there a role for ubiquinone supplementation? Am J Health Syst Pharm 61: 515-519, 2004.
23. Kroemer G. B709 mitochondrial control of cell death. Sci World J 1: 48, 2001.
24. Larner SF, Hayes RL, McKinsey DM, Pike BR, and Wang KK. Increased expression and processing of caspase-12 after traumatic brain injury in rats. J Neurochem 88: 78-90, 2004.
25. Laufs U and Liao JK. Isoprenoid metabolism and the pleiotropic effects of statins. Curr Atheroscler Rep 5: 372-378, 2003.
26. Li H, Zhu H, Xu CJ, and Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501, 1998.
27. Li X, Liu L, Tupper JC, Bannerman DD, Winn RK, Sebti SM, Hamilton AD, and Harlan JM. Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells. J Biol Chem 277: 15309-15316, 2002.
28. Liao JK. Isoprenoids as mediators of the biological effects of statins. J Clin Invest 110: 285-288, 2002.
29. Liston P, Young SS, Mackenzie AE, and Korneluk RG. Life and death decisions: the role of the IAPs in modulating programmed cell death. Apoptosis 2: 423-441, 1997.
30. Matzno S, Yasuda S, Juman S, Yamamoto Y, Nagareya-Ishida N, Tazuya-Murayama K, Nakabayashi T, and Matsuyama K. Statin-induced apoptosis linked with membrane farnesylated Ras small G protein depletion, rather than geranylated Rho protein. J Pharm Pharmacol 57: 1475-1484, 2005.
31. Muchmore SW, Sattler M, Liang H, Meadows RP, Harlan JE, Yoon HS, Nettesheim D, Chang BS, Thompson CB, Wong SL, Ng SL, and Fesik SW. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381: 335-341, 1996.
32. Mutoh T, Kumano T, Nakagawa H, and Kuriyama M. Involvement of tyrosine phosphorylation in HMG-CoA reductase inhibitor-induced cell death in L6 myoblasts. FEBS Lett 444: 85-89, 1999.
33. Nagashima T, Okazaki H, Yudoh K, Matsuno H, and Minota S. Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation: a potential therapeutic approach to rheumatoid arthritis. Arthritis Rheum 54: 579-586, 2006.
34. Phaneuf S and Leeuwenburgh C. Cytochrome c release from mitochondria in the aging heart: a possible mechanism for apoptosis with age. Am J Physiol Regul Integr Comp Physiol 282: R423-R430, 2002.
35. Pollack M and Leeuwenburgh C. Apoptosis and aging: role of the mitochondria. J Gerontol A Biol Sci Med Sci 56: B475-482, 2001.
36. Pollack M, Phaneuf S, Dirks A, and Leeuwenburgh C. The role of apoptosis in the normal aging brain, skeletal muscle, and heart. Ann NY Acad Sci 959: 93-107, 2002.
37. Raja SG and Dreyfus GD. Statins: much more than just a lipid-lowering therapy. Indian Heart J 56: 204-209, 2004.
38. Rao RV, Hermel E, Castro-Obregon S, del Rio G, Ellerby LM, Ellerby HM, and Bredesen DE. Coupling endoplasmic reticulum stress to the cell death program. Mechanism of caspase activation. J Biol Chem 276: 33869-33874, 2001.
39. Renatus M, Stennicke HR, Scott FL, Liddington RC, and Salvesen GS. Dimer formation drives the activation of the cell death protease caspase 9. Proc Natl Acad Sci USA 98: 14250-14255, 2001.
40. Sacher J, Weigl L, Werner M, Szegedi C, and Hohenegger M. Delineation of myotoxicity induced by 3-hydroxy-3-methylglutaryl CoA reductase inhibitors in human skeletal muscle cells. J Pharmacol Exp Ther 314: 1032-1041, 2005.
41. Seachrist JL, Loi CM, Evans MG, Criswell KA, and Rothwell CE. Roles of exercise and pharmacokinetics in cerivastatin-induced skeletal muscle toxicity. Toxicol Sci 88: 551-561, 2005.
42. Shibata M, Hattori H, Sasaki T, Gotoh J, Hamada J, and Fukuuchi Y. Activation of caspase-12 by endoplasmic reticulum stress induced by transient middle cerebral artery occlusion in mice. Neuroscience 118: 491-499, 2003.
43. Sun XM, MacFarlane M, Zhuang J, Wolf BB, Green DR, and Cohen GM. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J Biol Chem 274: 5053-5060, 1999.
44. Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K, and Takahashi R. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell 8: 613-621, 2001.
45. Thompson PD, Clarkson PM, and Rosenson RS. An assessment of statin safety by muscle experts. Am J Cardiol 97: S69-76, 2006.
46. Tomlinson SS and Mangione KK. Potential adverse effects of statins on muscle. Phys Ther 85: 459-465, 2005.
47. Vaux DL and Silke J. Mammalian mitochondrial IAP binding proteins. Biochem Biophys Res Commun 304: 499-504, 2003.
48. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, and Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275: 1129-1132, 1997.
49. Zhong WB, Wang CY, Chang TC, and Lee WS. Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibition of protein geranylgeranylation and de novo protein synthesis. Endocrinology 144: 3852-3859, 2003.
50. Zimmermann KC, Bonzon C, and Green DR. The machinery of programmed cell death. Pharmacol Ther 92: 57-70, 2001.